Results 221 to 230 of about 1,509,749 (267)

Advertising and child health

BMJ Paediatrics Open
Imti Choonara
doaj   +1 more source

Assessing the approach to perinatal mental health screening and treatment in maternal-child health clinics in Western Kenya. [PDF]

PLOS Glob Public Health
Neema A, Larsen A, Karume AK, Kaggiah A, Wagner AD, Richardson B, Weiner B, Maina C, Ndambuki C, Owaga D, Ngumbau N, Pothan L, Wang Y, Rose A, Ongeri L, Bhat A, Ronen K, Kinuthia J.   +17 more
europepmc   +1 more source

The Tale of the Residual Tail: Insights From Continuous Intracranial Monitoring From Post‐Hippocampectomy Dynamics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Subtotal hippocampal resection can leave residual hippocampal tissue, yet the immediate postoperative electrophysiologic evolution of such remnants is unknown. We describe a patient with drug‐resistant temporal lobe epilepsy in whom a hippocampal remnant was continuously monitored using a responsive neurostimulator (RNS) following subtotal ...
Patrick Hartnett, Syeda Amrah Hashmi, Amaan Qureshi, Heather Spader, Shayan Moosa, Ifrah Zawar   +5 more
wiley   +1 more source

A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial. [PDF]

Nat Med
Mshamu S, Mukaka M, Sanga C, Kambanga S, Rutaihwa AD, Bøjstrup TC, Meta J, Mmbando A, Pell C, Adhikari B, Olotu AI, Kapologwe N, White NJ, Dondorp AM, Day NPJ, Imwong M, Deen J, Lindsay SW, Knudsen JB, von Seidlein L.   +19 more
europepmc   +1 more source

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru, Akansha Chandrasekar, Kyla Blasingame, Jonathan Rosen, Jesse M. Levine, Karla Salazar, Madhuri Chilakapati, Rod Foroozan, Victoria Hardwick, Jonathan M. Yarimi, Nikita Shukla, Timothy E. Lotze, Kristen S. Fisher, Alexander J. Sandweiss   +13 more
wiley   +1 more source

Child health services research with the people who know best: experiences and lessons from CanChild's collaborations with families. [PDF]

Front Public Health
Chambers E, Cross A, Grahovac D, Hughes D, Micsinszki S, Novak-Pavlic M, Pozniak K, Rosenbaum P, Teplicky R, Tomas V, Wright M.   +10 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Per- and Polyfluoroalkyl Substances During Pregnancy and Gestational Diabetes: The Environmental Influences on Child Health Outcomes (ECHO) Cohort. [PDF]

Diabetes Care
Starling AP, Burjak M, Nzegwu AW, Xun X, Adgate JL, Barrett ES, Bennett DH, Chatzi L, Colicino E, Dabelea D, Dunlop AL, Eick SM, Farzan SF, Ferrara A, Fleisch AF, Geiger SD, Hedderson MM, Kahn LG, Karagas MR, Kelly RS, Liang D, Lin PI, O'Connor TG, Padula AM, Peterson AK, Romano ME, Sathyanarayana S, Zhu Y, Valvi D, ECHO Cohort Consortium*.   +29 more
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries. [PDF]

J Pharm Policy Pract
Briggs J, Kikule K, Walkowiak H, Guzman J, Embrey M, Petach H, Fikiri J, Mwesigye JP, Azad AK, Namugambe JS, Shedafa R, Trap B, Goita AK, Kaale E.   +13 more
europepmc   +1 more source